Freshpaint vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
HIPAA-compliant analytics infrastructure for healthcare; strips PHI from tracking events before reaching Google Analytics, Meta, or other marketing tools.
About
Freshpaint is a healthcare data privacy and analytics infrastructure platform that enables digital health companies and hospitals to run marketing analytics and tracking without violating HIPAA. Founded in 2019 and headquartered in San Francisco, Freshpaint solves a critical compliance challenge: standard web analytics tools (Google Analytics, Meta Pixel, Mixpanel) capture Protected Health Information (PHI) when embedded on healthcare websites, creating HIPAA liability. Freshpaint intercepts and sanitizes tracking events before they reach third-party analytics vendors.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.